These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 17869234)

  • 21. Prognostic utility of apoB/AI, total cholesterol/HDL, non-HDL cholesterol, or hs-CRP as predictors of clinical risk in patients receiving statin therapy after acute coronary syndromes: results from PROVE IT-TIMI 22.
    Ray KK; Cannon CP; Cairns R; Morrow DA; Ridker PM; Braunwald E
    Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):424-30. PubMed ID: 19122170
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ApoB/ApoA-I ratio in young patients with ischemic cerebral stroke or peripheral arterial disease.
    Sabino AP; De Oliveira Sousa M; Moreira Lima L; Dias Ribeiro D; Sant'Ana Dusse LM; Das Graças Carvalho M; Fernandes AP
    Transl Res; 2008 Sep; 152(3):113-8. PubMed ID: 18774540
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The cost-effectiveness of an early interventional strategy in non-ST-elevation acute coronary syndrome based on the RITA 3 trial.
    Henriksson M; Epstein DM; Palmer SJ; Sculpher MJ; Clayton TC; Pocock SJ; Henderson RA; Buxton MJ; Fox KA
    Heart; 2008 Jun; 94(6):717-23. PubMed ID: 18032459
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost-effectiveness of cardiac rehabilitation program delivery models in patients at varying cardiac risk, reason for referral, and sex.
    Papadakis S; Reid RD; Coyle D; Beaton L; Angus D; Oldridge N
    Eur J Cardiovasc Prev Rehabil; 2008 Jun; 15(3):347-53. PubMed ID: 18525392
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-sensitivity C-reactive protein in the exhaled breath condensate and serum in stable and unstable asthma.
    Zietkowski Z; Tomasiak-Lozowska MM; Skiepko R; Mroczko B; Szmitkowski M; Bodzenta-Lukaszyk A
    Respir Med; 2009 Mar; 103(3):379-85. PubMed ID: 19010654
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pregnancy-associated plasma protein-A elevation in patients with acute coronary syndrome and subsequent atorvastatin therapy.
    Miedema MD; Conover CA; MacDonald H; Harrington SC; Oberg D; Wilson D; Henry TD; Schwartz RS
    Am J Cardiol; 2008 Jan; 101(1):35-9. PubMed ID: 18157962
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The prevalence of angiographically significant coronary artery disease in patients with isolated secundum atrial septal defect].
    Cay S; Oztürk S; Cağirci G; Yetim M; Büyükterzi Z
    Turk Kardiyol Dern Ars; 2008 Oct; 36(7):451-5. PubMed ID: 19155658
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Inflammation and C-reactive protein in cardiovascular disease].
    Munk PS; Larsen AI
    Tidsskr Nor Laegeforen; 2009 Jun; 129(12):1221-4. PubMed ID: 19521445
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of fluvastatin extended-release (80 mg) alone and in combination with ezetimibe (10 mg) on low-density lipoprotein cholesterol and inflammatory parameters in patients with primary hypercholesterolemia: a 12-week, multicenter, randomized, open-label, parallel-group study.
    Alvarez-Sala LA; Cachofeiro V; Masana L; Suarez C; Pinilla B; Plana N; Trias F; Moreno MA; Gambus G; Lahera V; Pintó X
    Clin Ther; 2008 Jan; 30(1):84-97. PubMed ID: 18343245
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Markers of inflammation and prevalence of vascular disease in patients with metabolic syndrome.
    Novo G; Corrado E; Muratori I; Tantillo R; Bellia A; Galluzzo A; Vitale G; Novo S
    Int Angiol; 2007 Dec; 26(4):312-7. PubMed ID: 18091698
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term economic outcomes associated with intensive versus moderate lipid-lowering therapy in coronary artery disease: results from the Treating to New Targets (TNT) Trial.
    Mark DB; Knight JD; Cowper PA; Davidson-Ray L; Anstrom KJ
    Am Heart J; 2008 Oct; 156(4):698-705. PubMed ID: 18926150
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost implications of initial computed tomography angiography as opposed to catheterization in patients with mildly abnormal or equivocal myocardial perfusion scans.
    Cole JH; Chunn VM; Morrow JA; Buckley RS; Phillips GM
    J Cardiovasc Comput Tomogr; 2007 Jul; 1(1):21-6. PubMed ID: 19083872
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Myocardial injury in coronary artery bypass grafting: on-pump versus off-pump comparison by measuring high-sensitivity C-reactive protein, cardiac troponin I, heart-type fatty acid-binding protein, creatine kinase-MB, and myoglobin release.
    Chowdhury UK; Malik V; Yadav R; Seth S; Ramakrishnan L; Kalaivani M; Reddy SM; Subramaniam GK; Govindappa R; Kakani M
    J Thorac Cardiovasc Surg; 2008 May; 135(5):1110-9, 1119.e1-10. PubMed ID: 18455592
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictors of target lesion revascularization in patients undergoing lower extremity percutaneous interventions.
    Shammas NW; Shammas G; Bryan D; Rauba J; Dippel E; Jerin M
    J Invasive Cardiol; 2009 Jun; 21(6):266-9. PubMed ID: 19494402
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biomarker analysis by fluorokine multianalyte profiling distinguishes patients requiring intervention from patients with long-term quiescent coronary artery disease: a potential approach to identify atherosclerotic disease progression.
    Gurbel PA; Kreutz RP; Bliden KP; DiChiara J; Tantry US
    Am Heart J; 2008 Jan; 155(1):56-61. PubMed ID: 18082490
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Screening for significant coronary artery disease in high-risk renal transplant candidates.
    Gowdak LH; de Paula FJ; César LA; Martinez Filho EE; Ianhez LE; Krieger EM; Ramires JA; de Lima JJ
    Coron Artery Dis; 2007 Nov; 18(7):553-8. PubMed ID: 17925609
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oxidative stress and inflammation due to peripheral polymorphonuclear leukocytes after coronary angiography vs percutaneous coronary intervention.
    Farah R; Shurtz-Swirski R; Bolotin Y; Brezins M
    Minerva Cardioangiol; 2008 Apr; 56(2):189-95. PubMed ID: 18319697
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Costs and clinical outcomes in individuals without known coronary artery disease undergoing coronary computed tomographic angiography from an analysis of Medicare category III transaction codes.
    Min JK; Shaw LJ; Berman DS; Gilmore A; Kang N
    Am J Cardiol; 2008 Sep; 102(6):672-8. PubMed ID: 18773986
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic value of plasma fibronectin level in predicting the presence and severity of coronary artery disease.
    Ozcelik F; Erdogan O; Aktoz M; Ekuklu G; Tatli E; Demir M
    Ann Hematol; 2009 Mar; 88(3):249-53. PubMed ID: 18716775
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost-effectiveness of early versus selectively invasive strategy in patients with acute coronary syndromes without ST-segment elevation.
    Dijksman LM; Hirsch A; Windhausen F; Asselman FF; Tijssen JG; Dijkgraaf MG; de Winter RJ;
    Int J Cardiol; 2009 Jan; 131(2):204-11. PubMed ID: 18199496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.